UK health authorities are warning physicians and the medical community in Britain that people with “a significant history of allergic reactions” should not be administered the BNT162b2 vaccine from Pfizer/BioNTech as two healthcare workers developed material symptoms after receiving a jab just a day prior. This precautionary guidance has been announced once the two individuals “responded adversely” after they received their shots during the first day of a mass vaccination event in the UK, reported UK National Health Service.
Stephen Powis, national Medical Director for the NHS, commented, “As is common with new vaccines, the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination.”
Although both individuals appear to be getting better, it could be viewed somewhat concerning that after about 30,000 people were tested during clinical trials that this type of reaction wasn’t identified. On the other hand, as shared by Powis, this may be a normal occurrence with a new vaccine.
In a CNN piece, vaccine expert Dr. Paul Offit shared that this type of event is not uncommon. In the U.S., about 1.4 million doses of vaccines trigger severe allergic reaction complications reported the doctor. While Pfizer/BioNTech report there are “no serious safety concerns over this vaccine.”